nodes	percent_of_prediction	percent_of_DWPC	metapath
Mazindol—SLC6A3—Parkinson's disease	0.778	1	CbGaD
Mazindol—SLC6A2—locus ceruleus—Parkinson's disease	0.0118	0.147	CbGeAlD
Mazindol—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00936	0.117	CbGeAlD
Mazindol—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00696	0.0866	CbGeAlD
Mazindol—SLC6A2—autonomic nervous system—Parkinson's disease	0.00629	0.0783	CbGeAlD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—PITX3—Parkinson's disease	0.00575	0.043	CbGpPWpGaD
Mazindol—SLC6A3—Clearance of dopamine—COMT—Parkinson's disease	0.00468	0.0349	CbGpPWpGaD
Mazindol—SLC6A3—Clearance of dopamine—MAOA—Parkinson's disease	0.00464	0.0347	CbGpPWpGaD
Mazindol—SLC6A3—nerve—Parkinson's disease	0.00439	0.0546	CbGeAlD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—LMX1A—Parkinson's disease	0.00436	0.0326	CbGpPWpGaD
Mazindol—SLC6A3—Alpha-synuclein signaling—SNCAIP—Parkinson's disease	0.00361	0.027	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—PINK1—Parkinson's disease	0.00361	0.027	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—SEPT5—Parkinson's disease	0.00361	0.027	CbGpPWpGaD
Mazindol—SLC6A2—nerve—Parkinson's disease	0.00354	0.0441	CbGeAlD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—EN1—Parkinson's disease	0.0033	0.0247	CbGpPWpGaD
Mazindol—SLC6A3—hindbrain—Parkinson's disease	0.00328	0.0409	CbGeAlD
Mazindol—SLC6A3—Parkinsons Disease Pathway—SNCAIP—Parkinson's disease	0.00307	0.0229	CbGpPWpGaD
Mazindol—SLC6A4—hindbrain—Parkinson's disease	0.00301	0.0375	CbGeAlD
Mazindol—SLC6A3—Parkinsons Disease Pathway—HTRA2—Parkinson's disease	0.00274	0.0204	CbGpPWpGaD
Mazindol—SLC6A4—Monoamine Transport—DBH—Parkinson's disease	0.00265	0.0198	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—ATXN2—Parkinson's disease	0.00233	0.0174	CbGpPWpGaD
Mazindol—SLC6A2—Monoamine Transport—DBH—Parkinson's disease	0.00228	0.017	CbGpPWpGaD
Mazindol—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.00216	0.0161	CbGpPWpGaD
Mazindol—SLC6A4—Serotonin Transporter Activity—MAOA—Parkinson's disease	0.00216	0.0161	CbGpPWpGaD
Mazindol—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.00213	0.0159	CbGpPWpGaD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—NR4A2—Parkinson's disease	0.00213	0.0159	CbGpPWpGaD
Mazindol—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.00212	0.0158	CbGpPWpGaD
Mazindol—SLC6A3—Alpha-synuclein signaling—PARK7—Parkinson's disease	0.00207	0.0155	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—GPR37—Parkinson's disease	0.00207	0.0155	CbGpPWpGaD
Mazindol—SLC6A3—Monoamine Transport—DBH—Parkinson's disease	0.00202	0.0151	CbGpPWpGaD
Mazindol—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.00192	0.0143	CbGpPWpGaD
Mazindol—SLC6A3—Alpha-synuclein signaling—UCHL1—Parkinson's disease	0.0019	0.0142	CbGpPWpGaD
Mazindol—SLC6A3—brainstem—Parkinson's disease	0.00188	0.0234	CbGeAlD
Mazindol—SLC6A3—Alpha-synuclein signaling—GRK5—Parkinson's disease	0.00185	0.0138	CbGpPWpGaD
Mazindol—SLC6A4—Synaptic Vesicle Pathway—PARK7—Parkinson's disease	0.00183	0.0137	CbGpPWpGaD
Mazindol—SLC6A3—forebrain—Parkinson's disease	0.00182	0.0226	CbGeAlD
Mazindol—SLC6A3—Parkinsons Disease Pathway—PARK7—Parkinson's disease	0.00176	0.0132	CbGpPWpGaD
Mazindol—SLC6A4—brainstem—Parkinson's disease	0.00173	0.0215	CbGeAlD
Mazindol—SLC6A4—forebrain—Parkinson's disease	0.00167	0.0207	CbGeAlD
Mazindol—SLC6A3—Alpha-synuclein signaling—SNCA—Parkinson's disease	0.00166	0.0124	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—UCHL1—Parkinson's disease	0.00161	0.012	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—LRRK2—Parkinson's disease	0.00157	0.0117	CbGpPWpGaD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—DDC—Parkinson's disease	0.00156	0.0117	CbGpPWpGaD
Mazindol—SLC6A2—brainstem—Parkinson's disease	0.00152	0.0189	CbGeAlD
Mazindol—SLC6A2—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.0015	0.0112	CbGpPWpGaD
Mazindol—SLC6A2—forebrain—Parkinson's disease	0.00147	0.0183	CbGeAlD
Mazindol—SLC6A4—Monoamine Transport—ADORA2A—Parkinson's disease	0.00145	0.0109	CbGpPWpGaD
Mazindol—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Parkinson's disease	0.00142	0.0106	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—SNCA—Parkinson's disease	0.00141	0.0105	CbGpPWpGaD
Mazindol—SLC6A3—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.00133	0.00992	CbGpPWpGaD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—SLC18A2—Parkinson's disease	0.00133	0.00992	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—DDC—Parkinson's disease	0.00129	0.00966	CbGpPWpGaD
Mazindol—SLC6A3—Alpha-synuclein signaling—MAOB—Parkinson's disease	0.00128	0.00957	CbGpPWpGaD
Mazindol—SLC6A2—Monoamine Transport—ADORA2A—Parkinson's disease	0.00125	0.00934	CbGpPWpGaD
Mazindol—SLC6A3—midbrain—Parkinson's disease	0.0012	0.0149	CbGeAlD
Mazindol—SIGMAR1—medulla oblongata—Parkinson's disease	0.00119	0.0149	CbGeAlD
Mazindol—SLC6A3—Alpha-synuclein signaling—PARK2—Parkinson's disease	0.00118	0.00882	CbGpPWpGaD
Mazindol—SLC6A3—spinal cord—Parkinson's disease	0.00117	0.0146	CbGeAlD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00116	0.00866	CbGpPWpGaD
Mazindol—SLC6A4—Synaptic Vesicle Pathway—SLC18A2—Parkinson's disease	0.00114	0.00852	CbGpPWpGaD
Mazindol—SLC6A3—Monoamine Transport—ADORA2A—Parkinson's disease	0.00111	0.00827	CbGpPWpGaD
Mazindol—SLC6A4—midbrain—Parkinson's disease	0.0011	0.0137	CbGeAlD
Mazindol—SIGMAR1—midbrain—Parkinson's disease	0.00109	0.0136	CbGeAlD
Mazindol—SLC6A4—Monoamine Transport—TH—Parkinson's disease	0.00109	0.00811	CbGpPWpGaD
Mazindol—SLC6A4—Monoamine Transport—SLC6A3—Parkinson's disease	0.00109	0.00811	CbGpPWpGaD
Mazindol—SLC6A4—spinal cord—Parkinson's disease	0.00107	0.0134	CbGeAlD
Mazindol—SIGMAR1—spinal cord—Parkinson's disease	0.00107	0.0133	CbGeAlD
Mazindol—SLC6A2—medulla oblongata—Parkinson's disease	0.00106	0.0132	CbGeAlD
Mazindol—SLC6A4—Serotonin Transporter Activity—IL1B—Parkinson's disease	0.00104	0.00778	CbGpPWpGaD
Mazindol—SLC6A3—head—Parkinson's disease	0.00104	0.013	CbGeAlD
Mazindol—SLC6A3—Parkinsons Disease Pathway—PARK2—Parkinson's disease	0.001	0.0075	CbGpPWpGaD
Mazindol—SLC6A3—nervous system—Parkinson's disease	0.000986	0.0123	CbGeAlD
Mazindol—SLC6A2—Amine compound SLC transporters—SLC6A3—Parkinson's disease	0.000984	0.00735	CbGpPWpGaD
Mazindol—SLC6A4—head—Parkinson's disease	0.000953	0.0119	CbGeAlD
Mazindol—SLC6A3—central nervous system—Parkinson's disease	0.00095	0.0118	CbGeAlD
Mazindol—SLC6A2—Monoamine Transport—TH—Parkinson's disease	0.000934	0.00698	CbGpPWpGaD
Mazindol—SLC6A2—Monoamine Transport—SLC6A3—Parkinson's disease	0.000934	0.00698	CbGpPWpGaD
Mazindol—SLC6A3—cerebellum—Parkinson's disease	0.000928	0.0116	CbGeAlD
Mazindol—SLC6A4—nervous system—Parkinson's disease	0.000904	0.0113	CbGeAlD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000879	0.00657	CbGpPWpGaD
Mazindol—SLC6A3—Dopaminergic Neurogenesis—TH—Parkinson's disease	0.000871	0.00651	CbGpPWpGaD
Mazindol—SLC6A4—central nervous system—Parkinson's disease	0.00087	0.0108	CbGeAlD
Mazindol—SLC6A3—Alpha-synuclein signaling—TH—Parkinson's disease	0.000849	0.00634	CbGpPWpGaD
Mazindol—SIGMAR1—cerebellum—Parkinson's disease	0.000845	0.0105	CbGeAlD
Mazindol—SLC6A2—head—Parkinson's disease	0.000839	0.0105	CbGeAlD
Mazindol—Haloperidol—GRIN2B—Parkinson's disease	0.000833	0.109	CrCbGaD
Mazindol—SLC6A3—Monoamine Transport—TH—Parkinson's disease	0.000828	0.00618	CbGpPWpGaD
Mazindol—SLC6A2—nervous system—Parkinson's disease	0.000796	0.00991	CbGeAlD
Mazindol—SLC6A2—central nervous system—Parkinson's disease	0.000766	0.00954	CbGeAlD
Mazindol—SLC6A3—brain—Parkinson's disease	0.000754	0.00939	CbGeAlD
Mazindol—SLC6A3—Parkinsons Disease Pathway—TH—Parkinson's disease	0.000721	0.00539	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—CYCS—Parkinson's disease	0.000693	0.00517	CbGpPWpGaD
Mazindol—SLC6A4—brain—Parkinson's disease	0.000691	0.0086	CbGeAlD
Mazindol—SIGMAR1—brain—Parkinson's disease	0.000686	0.00854	CbGeAlD
Mazindol—SLC6A3—Neuronal System—HCN3—Parkinson's disease	0.000623	0.00465	CbGpPWpGaD
Mazindol—SLC6A2—brain—Parkinson's disease	0.000608	0.00757	CbGeAlD
Mazindol—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000587	0.00438	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000549	0.0041	CbGpPWpGaD
Mazindol—SLC6A4—NRF2 pathway—GSTA4—Parkinson's disease	0.000546	0.00408	CbGpPWpGaD
Mazindol—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00054	0.00403	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000524	0.00391	CbGpPWpGaD
Mazindol—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00052	0.00388	CbGpPWpGaD
Mazindol—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000478	0.00357	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—GSTA4—Parkinson's disease	0.00047	0.00351	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000452	0.00338	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—DDC—Parkinson's disease	0.000448	0.00335	CbGpPWpGaD
Mazindol—SLC6A4—Monoamine Transport—IL1B—Parkinson's disease	0.000443	0.00331	CbGpPWpGaD
Mazindol—Haloperidol—DRD3—Parkinson's disease	0.000423	0.0554	CrCbGaD
Mazindol—SLC6A3—NRF2 pathway—GSTA4—Parkinson's disease	0.000416	0.00311	CbGpPWpGaD
Mazindol—Haloperidol—DRD1—Parkinson's disease	0.000415	0.0544	CrCbGaD
Mazindol—SLC6A3—Neuronal System—KCNJ4—Parkinson's disease	0.000401	0.003	CbGpPWpGaD
Mazindol—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000385	0.00287	CbGpPWpGaD
Mazindol—SLC6A2—Monoamine Transport—IL1B—Parkinson's disease	0.000381	0.00285	CbGpPWpGaD
Mazindol—Amoxapine—HTR7—Parkinson's disease	0.000373	0.0489	CrCbGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000369	0.00276	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000355	0.00265	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000354	0.00264	CbGpPWpGaD
Mazindol—Amoxapine—DRD3—Parkinson's disease	0.000351	0.046	CrCbGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00035	0.00261	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—DLG1—Parkinson's disease	0.000346	0.00259	CbGpPWpGaD
Mazindol—Amoxapine—DRD1—Parkinson's disease	0.000345	0.0452	CrCbGaD
Mazindol—Azelastine—CYP2E1—Parkinson's disease	0.000342	0.0448	CrCbGaD
Mazindol—SLC6A3—Monoamine Transport—IL1B—Parkinson's disease	0.000338	0.00252	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000334	0.0025	CbGpPWpGaD
Mazindol—SLC6A4—NRF2 pathway—NQO1—Parkinson's disease	0.000327	0.00244	CbGpPWpGaD
Mazindol—Amoxapine—SLC6A3—Parkinson's disease	0.000327	0.0428	CrCbGaD
Mazindol—SLC6A4—NRF2 pathway—HSPA1A—Parkinson's disease	0.000325	0.00243	CbGpPWpGaD
Mazindol—SLC6A4—NRF2 pathway—SLC6A3—Parkinson's disease	0.000323	0.00241	CbGpPWpGaD
Mazindol—SLC6A4—Monoamine Transport—TNF—Parkinson's disease	0.000322	0.0024	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000306	0.00228	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000301	0.00225	CbGpPWpGaD
Mazindol—SLC6A3—Parkinsons Disease Pathway—CASP3—Parkinson's disease	0.000294	0.00219	CbGpPWpGaD
Mazindol—Haloperidol—DRD2—Parkinson's disease	0.000293	0.0383	CrCbGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000291	0.00218	CbGpPWpGaD
Mazindol—Amoxapine—HTR1A—Parkinson's disease	0.000286	0.0375	CrCbGaD
Mazindol—SLC6A2—NRF2 pathway—NQO1—Parkinson's disease	0.000281	0.0021	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—DRD1—Parkinson's disease	0.00028	0.00209	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—HSPA1A—Parkinson's disease	0.000279	0.00209	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—SLC6A3—Parkinson's disease	0.000277	0.00207	CbGpPWpGaD
Mazindol—SLC6A2—Monoamine Transport—TNF—Parkinson's disease	0.000277	0.00206	CbGpPWpGaD
Mazindol—SLC6A4—NRF2 pathway—GSTP1—Parkinson's disease	0.000273	0.00204	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—DRD3—Parkinson's disease	0.000271	0.00203	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—GRIK1—Parkinson's disease	0.000271	0.00202	CbGpPWpGaD
Mazindol—SLC6A4—NRF2 pathway—HMOX1—Parkinson's disease	0.000269	0.00201	CbGpPWpGaD
Mazindol—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000267	0.00199	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000258	0.00193	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000255	0.00191	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000255	0.00191	CbGpPWpGaD
Mazindol—Azelastine—CYP2D6—Parkinson's disease	0.000251	0.0329	CrCbGaD
Mazindol—SLC6A4—NRF2 pathway—HGF—Parkinson's disease	0.000251	0.00187	CbGpPWpGaD
Mazindol—SLC6A4—NRF2 pathway—GSTM1—Parkinson's disease	0.000251	0.00187	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—TH—Parkinson's disease	0.00025	0.00187	CbGpPWpGaD
Mazindol—SLC6A3—NRF2 pathway—NQO1—Parkinson's disease	0.000249	0.00186	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000249	0.00186	CbGpPWpGaD
Mazindol—SLC6A3—NRF2 pathway—HSPA1A—Parkinson's disease	0.000248	0.00185	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—HTR7—Parkinson's disease	0.000245	0.00183	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—DRD2—Parkinson's disease	0.000245	0.00183	CbGpPWpGaD
Mazindol—SLC6A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000245	0.00183	CbGpPWpGaD
Mazindol—SLC6A3—Monoamine Transport—TNF—Parkinson's disease	0.000245	0.00183	CbGpPWpGaD
Mazindol—Clozapine—HTR7—Parkinson's disease	0.000245	0.0321	CrCbGaD
Mazindol—Amoxapine—DRD2—Parkinson's disease	0.000243	0.0318	CrCbGaD
Mazindol—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000236	0.00176	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—GSTP1—Parkinson's disease	0.000235	0.00175	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—HMOX1—Parkinson's disease	0.000232	0.00173	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000231	0.00172	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—GRIK2—Parkinson's disease	0.00023	0.00172	CbGpPWpGaD
Mazindol—Clozapine—DRD3—Parkinson's disease	0.00023	0.0302	CrCbGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000226	0.00169	CbGpPWpGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000226	0.00169	CbGpPWpGaD
Mazindol—Haloperidol—HTR2A—Parkinson's disease	0.000226	0.0296	CrCbGaD
Mazindol—Clozapine—DRD1—Parkinson's disease	0.000226	0.0296	CrCbGaD
Mazindol—SLC6A3—Neuronal System—SLC18A2—Parkinson's disease	0.000223	0.00167	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000221	0.00165	CbGpPWpGaD
Mazindol—SLC6A3—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000217	0.00162	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—GSTM1—Parkinson's disease	0.000216	0.00161	CbGpPWpGaD
Mazindol—SLC6A2—NRF2 pathway—HGF—Parkinson's disease	0.000216	0.00161	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000211	0.00158	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000211	0.00157	CbGpPWpGaD
Mazindol—SLC6A3—NRF2 pathway—GSTP1—Parkinson's disease	0.000208	0.00155	CbGpPWpGaD
Mazindol—Haloperidol—CYP2D6—Parkinson's disease	0.000207	0.0271	CrCbGaD
Mazindol—SLC6A3—NRF2 pathway—HMOX1—Parkinson's disease	0.000205	0.00153	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000198	0.00148	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000194	0.00145	CbGpPWpGaD
Mazindol—SLC6A3—NRF2 pathway—HGF—Parkinson's disease	0.000191	0.00143	CbGpPWpGaD
Mazindol—SLC6A3—NRF2 pathway—GSTM1—Parkinson's disease	0.000191	0.00143	CbGpPWpGaD
Mazindol—Amoxapine—HTR2A—Parkinson's disease	0.000188	0.0246	CrCbGaD
Mazindol—Clozapine—HTR1A—Parkinson's disease	0.000188	0.0246	CrCbGaD
Mazindol—Midazolam—CYP2E1—Parkinson's disease	0.000181	0.0237	CrCbGaD
Mazindol—Azelastine—ABCB1—Parkinson's disease	0.000179	0.0235	CrCbGaD
Mazindol—SLC6A3—Neuronal System—CHRNA4—Parkinson's disease	0.000177	0.00132	CbGpPWpGaD
Mazindol—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000175	0.00131	CbGpPWpGaD
Mazindol—Amoxapine—CYP2D6—Parkinson's disease	0.000172	0.0225	CrCbGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000162	0.00121	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—HSPA8—Parkinson's disease	0.000162	0.00121	CbGpPWpGaD
Mazindol—SLC6A3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000161	0.0012	CbGpPWpGaD
Mazindol—Clozapine—DRD2—Parkinson's disease	0.000159	0.0209	CrCbGaD
Mazindol—Diazepam—CYP2E1—Parkinson's disease	0.000155	0.0203	CrCbGaD
Mazindol—Clozapine—CYP2E1—Parkinson's disease	0.000153	0.0201	CrCbGaD
Mazindol—SLC6A3—Neuronal System—DLG4—Parkinson's disease	0.000152	0.00113	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—GRIN2B—Parkinson's disease	0.000149	0.00111	CbGpPWpGaD
Mazindol—Haloperidol—ABCB1—Parkinson's disease	0.000148	0.0194	CrCbGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000135	0.00101	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000125	0.000932	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000125	0.000931	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000125	0.00093	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—COMT—Parkinson's disease	0.000124	0.000929	CbGpPWpGaD
Mazindol—SLC6A3—Neuronal System—MAOA—Parkinson's disease	0.000124	0.000923	CbGpPWpGaD
Mazindol—Clozapine—HTR2A—Parkinson's disease	0.000123	0.0161	CrCbGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00012	0.000896	CbGpPWpGaD
Mazindol—Clozapine—CYP2D6—Parkinson's disease	0.000113	0.0148	CrCbGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00011	0.000825	CbGpPWpGaD
Mazindol—Midazolam—ABCB1—Parkinson's disease	9.5e-05	0.0125	CrCbGaD
Mazindol—SLC6A4—Circadian rythm related genes—MAPK8—Parkinson's disease	9.34e-05	0.000698	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	9.05e-05	0.000676	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.88e-05	0.000663	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.53e-05	0.000637	CbGpPWpGaD
Mazindol—Diazepam—ABCB1—Parkinson's disease	8.14e-05	0.0107	CrCbGaD
Mazindol—Clozapine—ABCB1—Parkinson's disease	8.04e-05	0.0105	CrCbGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.56e-05	0.000564	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.41e-05	0.000554	CbGpPWpGaD
Mazindol—SLC6A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.31e-05	0.000546	CbGpPWpGaD
Mazindol—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.12e-05	0.000531	CbGpPWpGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.57e-05	0.000491	CbGpPWpGaD
Mazindol—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.3e-05	0.000471	CbGpPWpGaD
Mazindol—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	5.97e-05	0.000446	CbGpPWpGaD
